Q2 Earnings Forecast for Vericel Issued By Leerink Partnrs
Vericel Co. (NASDAQ:VCEL – Free Report) – Equities research analysts at Leerink Partnrs lowered their Q2 2025 earnings per share estimates for shares of Vericel in a research note issued to investors on Thursday, February 27th. Leerink Partnrs analyst M. Kratky now expects that the biotechnology company will post earnings per share of ($0.01) for […]
Vericel Co. (NASDAQ:VCEL – Free Report) – Equities research analysts at Leerink Partnrs lowered their Q2 2025 earnings per share estimates for shares of Vericel in a research note issued to investors on Thursday, February 27th. Leerink Partnrs analyst M. Kratky now expects that the biotechnology company will post earnings per share of ($0.01) for […]
